The rapid rise of weight loss drugs is generating a host of new product lines as companies hope to land on the right side of the health care disruptor.
Dutch Bioscience firm DSM Firmenich told CNBC Wednesday that it is exploring nutritional supplements to complement and compensate for some of the impacts of the weight loss drugs.
Dutch Bioscience firm DSM Firmenich told CNBC Wednesday that it is exploring nutritional supplements to complement and compensate for some of the impacts of the weight loss drugs, with CEO Dimitri de Vreeze describing it as the natural progression for the industry. "There are some side effects of weight loss drugs and that means it's more difficult to build up muscle, it's more difficult to keep your protein level up. And here we come into play. We are using ingredients, developing ingredients where that's being sort of compensated for," he said.aimed at GLP-1 drug users.
"That said, consumers could also eat more weight management foods as they strive to eat healthier and substitute such products over more indulgent snacking alternatives," he added. "We think it is too early for investors to take definitive positioning outside of healthcare stocks on the impact of GLP-1 drugs, and the range of potential scenarios is very wide," Barclays analysts wrote.
The new products come as other pharmaceutical companies are nipping at the heels of Novo and Eli in a bid to claim a share of the weight loss pie.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Wegovy users keep weight off for 4 years: How Wegovy helps the heartPatients taking Novo Nordisk’s Wegovy obesity treatment maintained an average of 10% weight loss after four years, potentially boosting the drugmaker’s case to insurers and governments to cover the cost of the effective but expensive drug.
Read more »
Weight loss drugs Wegovy and Mounjaro could spawn a host of new piggyback product linesThe rapid rise of weight loss drugs Wegovy and Mounjaro is generating a host of new product lines as companies hope to land on the right side of the health care…
Read more »
Weight loss drugs Wegovy and Mounjaro could spawn a host of new piggyback product linesThe rapid rise of weight loss drugs Wegovy and Mounjaro is generating a host of new product lines as companies hope to land on the right side of the health care disruptor.
Read more »
Use of Wegovy and other weight-loss drugs soars among kids and young adultsUse of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and young adults
Read more »
Use of Wegovy and other weight-loss drugs soars among kids and young adultsUse of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and young adults.
Read more »
– Young Adults’ Use of Popular Weight Loss Drugs Wegovy and Ozempic Skyrockets by 594%Science, Space and Technology News 2024
Read more »